Synthetic biology is revolutionizing precision medicine by enabling the development of personalized treatments, advanced drug delivery systems, and cutting-edge diagnostic tools. Using technologies like CRISPR gene editing, synthetic gene circuits, and engineered cells, it offers tailored solutions for diseases such as cancer and genetic disorders. Despite the promise, challenges like safety concerns, ethical issues, and regulatory […]
Author Archives: truemeds
Cyclin-dependent kinases (CDKs) play a crucial role in regulating the cell cycle and are central to cancer development due to their frequent dysregulation. CDKs have become significant biomarkers for cancer prognosis, helping predict disease progression and response to treatments. The success of CDK inhibitors, particularly those targeting CDK4/6, has revolutionized cancer therapy, especially for hormone receptor-positive […]
Neurotherapeutics, The development of cyclin-dependent kinase 5 (Cdk5) inhibitors, particularly the novel compound 25–106, represents a promising avenue for therapeutic intervention in neuropsychiatric and neurodegenerative disorders. Cdk5 plays a crucial role in neuronal function and is implicated in diseases such as Alzheimer’s and Parkinson’s. Research into 25–106 highlights its potent inhibition of Cdk5 along with its […]
A common lipid-modifying medication, fenofibrate is crucial for treating dyslipidemia, particularly in patients with high triglyceride and cholesterol levels. Fenofibrate is a useful choice in the therapeutic and preventive approaches meant to lower cardiovascular risk. It has been approved by health authorities for the treatment of hypercholesterolemia and hypertriglyceridemia. It is usually administered in conjunction […]
Flunarizine, a calcium channel blocker, has gained recognition in neurology for its efficacy in preventing migraines and managing chronic vertigo and balance disorders. By selectively inhibiting calcium influx in neurons, Flunarizine stabilizes neuronal activity, reducing hyperexcitability linked to migraines and dizziness. Its neuroprotective and antihistamine properties further support its therapeutic applications, particularly for patients who […]
Challenges and Opportunities in Cancer Models of Aging. Age is one of the major risk factors for cancer, and most cancer cases are diagnosed in people over the age of 65, with 60% of new cancer diagnoses and 70% of cancer deaths occurring in this population. Any cancer research on adults faces the problem of […]
11
Jun
Jun
This article explores the potential of Fludarabine as a multi-targeted antiviral agent against the monkeypox virus, leveraging computational drug repurposing. Given the limited treatment options for monkeypox, this study focuses on inhibiting key viral proteins—A6R, D8L, and F13L—which are essential for viral replication, entry, and maturation. Through molecular docking, molecular dynamics (MD) simulation, and MM/GBSA […]
11
Jun
Jun
The Pentose Phosphate Pathway (PPP) plays a critical role in cancer cell metabolism, supporting their rapid growth and survival by providing essential metabolic intermediates and a robust antioxidant defense. This pathway consists of two phases: the oxidative phase, which produces NADPH for redox balance and biosynthetic needs, and the nonoxidative phase, which generates ribose-5-phosphate for […]
11
Jun
Jun
Interleukin-6 (IL-6) is a key cytokine that regulates immune responses, inflammation, and tumor progression. As a glycoprotein in the “4α-helix” cytokine family, IL-6 is encoded on chromosome 7p21 and is upregulated during infection, cellular damage, or immune activation. IL-6 signaling involves the IL-6 receptor (IL-6R) and gp130, activating pathways like JAK/STAT3, MAPK/ERK, and PI3K/Akt to […]
11
Jun
Jun
Selpercatinib is a RET kinase inhibitor that has emerged as a promising treatment for cancers driven by RET alterations, including non-small cell lung cancer (NSCLC) and medullary thyroid cancer. Its targeted mechanism of action allows it to specifically inhibit RET-positive tumors, providing effective cancer control with a generally manageable safety profile. Clinical trials have demonstrated […]